You are here: Home > Research & Development > Product Pipeline

  Product Pipeline and Commercial Products

 
 R&D Home
  
 
Technology
 
 Products
 
 Partners & Licensing
 
 Patents


 

 

    Commercial Products

 

Commercial Product

Branded Products
(a)

Therapeutic Category

Commercial Status

Partner

Hydromorphone Hydrochloride
8 mg tablets

Dilaudid®
8 mg

Pain

Launched

Owned by Elite,

distributed by Precision Dose, Inc. / TAGI

Lodrane D®

N/A

OTC Allergy

Launched

ECR Pharmaceuticals

Naltrexone Hydrochloride

50 mg

ReVia®

Opioid Antagonist

Launch pending

Owned by Elite, distributed by Precision Dose, Inc./ TAGI

Phentermine HCl

37.5 mg tablets

Adipex-P® 37.5 mg

Bariatric

Launched

Owned by Elite, distributed by Precision Dose, Inc./ TAGI

Phentermine HCI
15 mg capsules

Adipex-P®

Bariatric Launched Owned by Elite, distributed by Precision Dose, Inc./ TAGI

Phentermine HCI

30 mg capsules

Adipex-P®

Bariatric

Launched

Owned by Elite, distributed by Precision Dose, Inc./ TAGI

  

   Contract Manufacturing

  

Commercial Product

Branded Products
(a)

Therapeutic Category

Commercial Status

Partner

Methadone Hydrochloride

10 mg tablets

Dolophine® 
10 mg tablets

Pain

Launched

ThePharmaNetwork

Phendimetrazine Tartrate Tablets USP,
35 mg.

Bontril PDM

Bariatric

Launched

Mikah Pharma LLC

   

 

   Product Pipeline

       

Programs Under Development

Branded Products
(a)

Therapeutic Category

NDA / ANDA

Development Stage
 

Partner

Extended Release Opioids

N/A

Pain

ANDA / NDA

Scale up

Owned by Elite

Abuse Resistant Opioids (b)

N/A

Pain

ANDA / NDA

Scale up

Owned by Elite

Undisclosed Generic

Undisclosed

Undisclosed

ANDA

Pending FDA Approval

Owned by Elite

Undisclosed Intermediate Product

Undisclosed

Undisclosed

ANDA

Scale up

Hi-Tech Pharmacal

Undisclosed

N/A

Undisclosed

NDA

Development

Undisclosed

Undisclosed

Undisclosed

Undisclosed

NDA

Development

Mikah Pharma LLC

Lodrane®

24 hour products

NA

Allergy

NDA

Scale-up

ECR Pharmaceuticals

(a)    The name of our competitor’s branded product if our product is a generic product. 

(b)    Click here to view slide on How Elite's Abuse Resistant Technology Works

 

Elite Pharmaceuticals, Inc. 165 Ludlow Ave., Northvale, NJ 07647    Phone:  201-750-2646  Fax:  201-750-2755 
E Mail:  webmaster@elitepharma.com